Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients
- DOI
- 10.1007/bf03018406
- Published
- 2004-06
- Container
- Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/bf03018406,
title = {Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients},
author = {Osama Almuslim and David Leasa},
year = {2004},
journal = {Canadian Journal of Anesthesia/Journal canadien d'anesthésie},
doi = {10.1007/bf03018406},
url = {https://doi.org/10.1007/bf03018406}
}RIS
TY - JOUR TI - Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients AU - Osama Almuslim AU - David Leasa PY - 2004 JO - Canadian Journal of Anesthesia/Journal canadien d'anesthésie DO - 10.1007/bf03018406 UR - https://doi.org/10.1007/bf03018406 ER -
APA
Almuslim, O., & Leasa, D. (2004). Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. https://doi.org/10.1007/bf03018406
Source records
- crossref · retrieved 2026-09-26T11:12:49.356Z